Autor(es): Russo, P ; Costa, M ; Silva, M ; de Sousa, A ; Carvalho, D ; Saiote, J ; Mendes, M
Data: 2017
Identificador Persistente: http://hdl.handle.net/10400.17/2784
Origem: Repositório do Centro Hospitalar de Lisboa Central, EPE
Assunto(s): HSAC GAS; HSAC NEU; CHLC CHBPT; Antiparkinson Agents; Parkinson Disease; Gastrointestinal Endoscopy; Gastrostomy/adverse effects
The continuous delivery of a levodopa/carbidopa gel suspension (Duodopa®) into the small bowel through a jejunal tube inserted via percutaneous endoscopic gastrostomy represents a new treatment method in advanced Parkinson disease. Some severe device-related complications have been described in the last few years. Some of them are associated with phytobezoar formation at the pigtail of the catheter. We present the case of a Parkinson disease patient treated with the Duodopa infusion system complicated by jejunal tube fistulization into the colon. We suggest a possible treatment strategy for this complication, which has not been described in the literature to date.
